{
  "thread": {
    "uuid": "a277ef0c31f84ad6a99e6956de08c8d33e40a601",
    "url": "https://finance.sina.com.cn/stock/aiassist/pzzd/2026-01-15/doc-inhhkmpv3315449.shtml?cref=cj",
    "site_full": "finance.sina.com.cn",
    "site": "sina.com.cn",
    "site_section": "https://finance.sina.cn/?from=redirect",
    "site_categories": [
      "tech",
      "top_news_hk",
      "top_news_sg",
      "top_news_tw",
      "top_news",
      "politics",
      "science and technology",
      "economy, business and finance"
    ],
    "section_title": "新浪财经_金融信息服务商",
    "site_title": "æ°æµªè´¢ç»_éèä¿¡æ¯æå¡å",
    "title": "惠泰医疗跌2.00%，成交额2.30亿元，主力资金净流入1197.36万元|医疗器械_新浪财经_新浪网",
    "title_full": "惠泰医疗跌2.00%，成交额2.30亿元，主力资金净流入1197.36万元|医疗器械_新浪财经_新浪网",
    "published": "2026-01-15T08:03:00.000+02:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "CN",
    "main_image": "",
    "performance_score": 0,
    "domain_rank": 548,
    "domain_rank_updated": "2026-01-11T23:00:00.000+02:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "a277ef0c31f84ad6a99e6956de08c8d33e40a601",
  "url": "https://finance.sina.com.cn/stock/aiassist/pzzd/2026-01-15/doc-inhhkmpv3315449.shtml?cref=cj",
  "ord_in_thread": 0,
  "author": "小浪财讯",
  "published": "2026-01-15T08:03:00.000+02:00",
  "title": "惠泰医疗跌2.00%，成交额2.30亿元，主力资金净流入1197.36万元|医疗器械_新浪财经_新浪网",
  "text": "1月15日， 惠泰医疗 盘中下跌2.00%，截至14:03，报254.55元/股，成交2.30亿元，换手率0.63%，总市值358.99亿元。\n资金流向方面，主力资金净流入1197.36万元，特大单买入1577.15万元，占比6.85%，卖出868.75万元，占比3.77%；大单买入3135.17万元，占比13.62%，卖出2646.21万元，占比11.50%。\n惠泰医疗今年以来股价涨4.64%，近5个交易日涨0.05%，近20日涨4.04%，近60日跌22.39%。\n资料显示，深圳惠泰医疗器械股份有限公司位于广东省深圳市南山区西丽街道松坪山社区松坪山朗山路11号同方信息港B栋601，成立日期2002年6月17日，上市日期2021年1月7日，公司主营业务涉及电生理和血管介入医疗器械的研发、生产和销售。主营业务收入构成为：冠脉通路类53.90%，电生理20.23%，外周介入类17.51%，OEM6.01%，非血管介入1.88%，其他(补充)0.46%。\n惠泰医疗所属申万行业为：医药生物-医疗器械-医疗耗材。所属概念板块包括：价值成长、MSCI中国、增持回购、融资融券、中盘等。\n截至9月30日，惠泰医疗股东户数5690.00，较上期增加26.25%；人均流通股24782股，较上期减少20.79%。2025年1月-9月，惠泰医疗实现营业收入18.67亿元，同比增长22.47%；归母净利润6.23亿元，同比增长18.02%。\n分红方面，惠泰医疗A股上市后累计派现5.14亿元。近三年，累计派现4.13亿元。\n机构持仓方面，截止2025年9月30日，惠泰医疗十大流通股东中，香港中央结算有限公司位居第三大流通股东，持股645.68万股，相比上期增加194.71万股。易方达上证科创板50ETF（588080）位居第五大流通股东，持股305.76万股，相比上期减少44.12万股。华夏上证科创板50成份ETF（588000）位居第六大流通股东，持股299.21万股，相比上期减少164.27万股。华宝中证医疗ETF（512170）位居第八大流通股东，持股241.96万股，相比上期减少34.45万股。易方达蓝筹精选混合（005827）位居第九大流通股东，持股190.01万股，为新进股东。",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "chinese",
  "sentiment": "negative",
  "categories": [
    "Economy, Business and Finance"
  ],
  "topics": [
    "Economy, Business and Finance->financial and economic news",
    "Economy, Business and Finance->market and exchange"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": true,
  "webz_reporter": false,
  "external_links": [],
  "external_images": [],
  "internal_images": [],
  "entities": {
    "persons": [],
    "locations": [],
    "organizations": []
  },
  "syndication": {
    "syndicated": null,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [
      "top_news_hk",
      "top_news_sg",
      "top_news_tw",
      "top_news"
    ],
    "bias": null,
    "source": {
      "type": null,
      "city": null,
      "state": null,
      "country": null,
      "domain_type": null,
      "agency": null,
      "organization_name": null
    }
  },
  "rating": null,
  "crawled": "2026-01-15T08:11:25.189+02:00",
  "updated": "2026-01-16T09:07:44.000+02:00"
}